Using QAPI in conjunction with innovative medical practices helps one nursing center cut back on its use of antipsychotics dramatically.
When the Centers for Medicare & Medicaid Services (CMS) revised its Five-Star Quality Rating System last year, it added two new Quality Measures: 1.) percent of long-stay residents who received an antipsychotic medication and 2.) percent of short-stay residents who newly received an antipsychotic medication.
Both measures pertain to residents who are prescribed the so-called “off-label” use of these medications; that is, without a diagnosis of schizophrenia, Huntington’s disease, or Tourette syndrome. Read more . . .
To read more.... The content of this page is limited to NAAP Members only as one of the many benefits of NAAP Membership.
If you wish to become a member and get all these benefits... Join NAAP now. If you're already a member, log in below: